Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baijin Granules for hyperuricemia (damp-heat internal accumulation) – randomized double-blind placebo-controlled dose-exploration phase II trial
CTR20243576Phase 2Active
- Sponsor
- South-Central University for Nationalities
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Baijin Granules in hyperuricemia, gout, sponsored by South-Central University for Nationalities. Started Sep 2024; status: active.
02
Drugs
Baijin Granules
03
Conditions
hyperuricemiagout
Beyond the preview
Go deeper on CTR20243576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243576.